Publicado el número 11 del volumen 26 de la revista AIDS

Revista AIDSLos usuarios de la red pueden acceder al texto completo de estos artículos a través de Hinari. Les proponemos algunos de los artículos publicados en este número:

Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity

The role of microRNAs in HIV-1 pathogenesis and therapy

A literature review of reporting standards of HIV progression models

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals

A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up

Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl

Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis

Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America

The prognostic value of baseline CD4+ cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting

Recovery of HIV service provision post-earthquake

Number of missed doses: why 1 × 7 does not make 7 × 1?

The role of individual-based models in understanding the potential impact of antiretroviral therapy for prevention